Laboratorios Richmond SACIF (RICH)

Buenos Aires
238.000
+1.000(+0.42%)
  • Volume:
    18
  • Bid/Ask:
    232.750/238.000
  • Day's Range:
    231.000 - 242.000

RICH Overview

Prev. Close
237
Day's Range
231-242
Revenue
19.06B
Open
231
52 wk Range
208.5-264
EPS
12
Volume
18
Market Cap
18.75B
Dividend (Yield)
1.6153
(0.68%)
Average Volume (3m)
13,455
P/E Ratio
19.74
Beta
0.4
1-Year Change
-5.58%
Shares Outstanding
80,751,487
Next Earnings Date
-
What is your sentiment on Laboratorios Richmond?
or
Vote to see community's results!

Laboratorios Richmond SACIF Company Profile

Laboratorios Richmond SACIF Company Profile

Employees
400
Market
Argentina

Laboratorios Richmond SACIF is an Argentina-based company, which is engaged in the development and manufacture of pharmaceuticals. The Company's product categories include: Antiviral, under the brands Ciganclor, Lazinevir, Leuzan, Mivuten, Probirase, Protease, Selmivir, Trivenz, Virontar, Virontar N, Virontar 600, Vuclodir, Zepril, Zetavudin, and Zetrotax; Oncologi and Oncohematologic, under the brands Bemux, Capecit, Doxetal, Drifen, Espasevit, Fontrax, Gezt, and Monofer, among others; Cardiovascular, under the brands Amze 5, Amze 10, Antiplaq, Bilip 10, Bilip 20, Tacardia, and Timezol 20, among others; Neuropsychiatric, under the brands Dalam 15, Dolofrix 10, Donepes 5, and Prilben 10, among others, as well as Hospital, under the brands Amidiaz, Dalam, and Fentax, among others.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuySellBuy
Technical IndicatorsStrong BuyStrong BuyBuyBuyBuy
SummaryStrong BuyStrong BuyStrong BuyNeutralBuy